View Older Stories View More Recent Stories

Mar 27, 2014 06:33AM Roth Capital Starts Active Power (ACPW) at Buy

Mar 26, 2014 06:56PM AGTC Announces Pricing of Initial Public Offering

Mar 26, 2014 12:29PM RGS Energy's (RGSE) New Financing Strategy Could Provide Upside; Roth Boosts PT to $6

Mar 26, 2014 08:17AM American Apparel (APP) Prices 61M Common Offering at 50c/Share

Mar 25, 2014 10:34AM Notable Analyst Rating Changes 03/25: (SOL) (RAX) (PCAR) Upgraded; (HIMX) (PHM) (ACI) Downgraded

Mar 25, 2014 09:27AM Pre-Open Stock Movers 3/25: (GALT) (ECYT) (RAX) Higher; (IDN) (HIMX) (GIII) Lower (more...)

Mar 25, 2014 08:53AM Roth Upgrades ReneSola (SOL) to Buy; Sees Outperformance Continuing on Strong Differentiation

Mar 25, 2014 08:34AM American Apparel (APP) Commences $30.5M Cmmon Stock Offering

Mar 25, 2014 07:55AM Roth Capital Upgrades Silvercrest Mines (SVLC) to Buy

Mar 25, 2014 06:57AM Roth Capital Upgrades ReneSola Ltd. (SOL) to Buy

Mar 24, 2014 02:56PM Stronger-than-Expected FY13 Results Set Rexahn Pharma (RNN) Up for Promising FY14 - Analyst

Mar 24, 2014 07:46AM Roth Cuts PT on Curis (CRIS) to $9; Erivedge Phase 2 Misses Roche's (RHHBY) Internal Expectations

Mar 21, 2014 07:08AM Palatin Technologies (PTN) is Ready to Soar; Roth Reaffirms 'Buy' Rating

Mar 20, 2014 11:08AM Synta Pharma (SNTA) Positive Trajectory Reinforced by Latest ENCHANT-1 Data - Roth

Mar 20, 2014 09:31AM Roth on Sidelines with Yingli Green Energy (YGE); Leverage Will Continue to Limit Upside

Mar 20, 2014 08:32AM Applied Optoelectronics (AAOI) Prices 3M Common Follow-On at $24.25/Share

Mar 20, 2014 08:30AM Applied Optoelectronics Announces Pricing of Follow-on Public Offering

Mar 19, 2014 09:14AM Roth Capital Starts Concert Pharmaceuticals (CNCE) at Buy

Mar 19, 2014 08:57AM Roth Lifts PT on SolarCity (SCTY) to $80; Notes GAAP Measures are Often Underestimated

Mar 18, 2014 02:50PM Roth Still Bullish on Ligand Pharma (LGND) Following NOXAFIL Approval (MRK)

Mar 18, 2014 07:35AM Roth Cuts PT on Galena Biopharma (GALE) on SEC Risk

Mar 14, 2014 02:14PM Roth Reaffirms Peregrine Pharma (PPHM) at Buy; Prelim. Bavituximab + Sorafenib Phase I/II is Positive

Mar 14, 2014 12:23PM Roth Keeps ImmunoCellular (IMUC) at Neutral; Sidelined Until ICT-107 Picture Clears

Mar 14, 2014 10:37AM Notable Analyst Rating Changes 03/14: (TEVA) (SIRI) (LOW) Upgraded; (PLUG) (XOXO) (NUE) Downgraded

Mar 14, 2014 10:17AM Roth Keeps Keryx Biopharma (KERX) at Buy; Zerenex Potential Remains Strong

Mar 14, 2014 09:30AM Pre-Open Stock Movers 3/14: (HART) (MEET) (LMCA) Higher; (ARO) (ZBB) (PLUG) Lower (more...)

Mar 14, 2014 06:40AM Roth Capital Downgrades Plug Power (PLUG) to Neutral

Mar 13, 2014 08:53AM GenVec (GNVC) to Place $9M of Common at $3.15/Share

Mar 11, 2014 05:12PM TG Therapeutics, Inc. Announces $18.1 Million Underwritten Sale of Common Stock to a Single Institutional Investor

Mar 11, 2014 01:03PM OXiGENE Announces Updated Time for Presentation at the ROTH Conference

Mar 11, 2014 10:46AM Roth Boosts PT on Hydrogenics (HYGS) to $40; P2G Will Eventually Provide Long-Term Growth

Mar 11, 2014 10:37AM Key Takeaways From ROTH 2014 OC Conference (SCTY) (CSIQ) (JASO)

Mar 11, 2014 08:45AM Odyssey Marine Exploration Reports Record Fourth Quarter and Full Year 2013 Results

Mar 10, 2014 12:53PM Can-Fite BioPharma (CANF) Closes 1.48M ADS, Warrants Private Placement

Mar 7, 2014 02:06PM Roth Starts JA Solar (JASO) at Buy; Undervalued Name has Robust Balance Sheet, Strong Pipeline

Mar 7, 2014 12:58PM Electrovaya to Present at the Roth Capital Conference on March 12, 2014

Mar 7, 2014 12:07PM BioLineRx (BLRX) Closes 9.66M ADS Offering for Gross Proceeds of $24.1M

Mar 7, 2014 12:06PM Peregrine (PPHM) Risk/Reward Still Favorable; Plenty to Look Forward to in FY14 - Roth

Mar 7, 2014 10:45AM Notable Analyst Rating Changes 03/07: (GTAT) (CCRN) (PRU) Upgraded; (ALU) (NMRX) (VMEM) Downgraded

Mar 7, 2014 09:49AM Roth Capital Starts JA Solar Holdings Co., Ltd. (JASO) at Buy

Mar 7, 2014 09:20AM Roth Capital Starts Applied Micro Circuits (AMCC) at Buy

Mar 7, 2014 09:00AM OXiGENE Announces Presentation at the ROTH Conference on March 11, 2014

Mar 7, 2014 08:57AM Roth Keeps Spectrum Pharma (SPPI) at Buy; Q4 Results are Speed Bump on Road to Profitability

Mar 7, 2014 07:00AM AETI CEO to Present at ROTH Capital Partners 26th Annual Growth Stock Conference

Mar 7, 2014 06:50AM Roth Capital Starts Conatus Pharmaceuticals (CNAT) at Buy

Mar 7, 2014 06:49AM Roth Capital Downgrades Kindred Biosciences (KIN) to Neutral

Mar 7, 2014 06:10AM Applied Optoelectronics (AAOI) Announces 1.3M Common Follow-On Offering

Mar 6, 2014 05:45PM Applied Optoelectronics Files Registration Statement for Proposed Follow-on Public Offering

Mar 6, 2014 11:33AM Roth Keeps Verastem (VSTM) at Buy; Sees Positioned for 'Potentially Transformative Year'

Mar 6, 2014 11:07AM Pixelworks (PXLW) PT Raised to $10 at Roth

View More Recent Stories View Older Stories